Access cutting-edge pneumococcal disease treatment through this clinical trial at a research site in Glendale. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Glendale location
Access pneumococcal disease specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related pneumococcal disease treatment provided free
Check if you qualify for this pneumococcal disease clinical trial in Glendale, AZ
No-Cost Study Care
Local to Glendale
Convenient for AZ residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
This study is a Phase 3, randomized, modified double-blind study which aims to measure whether PCV21 vaccine (investigational pneumococcal conjugate vaccine) is safe and can help the body to develop germ-fighting agents called "antibodies" (immunogenicity) compared with 20-valent pneumococcal vaccine (Prevnar 20, licensed pneumococcal conjugate vaccine) when they are administered with routine pediatric vaccines in infants aged from approximately 2 months (42 to 89 days). The study duration per
Sponsor: Sanofi Pasteur, a Sanofi Company
Yes, this clinical trial (NCT06736041) has an active research site in Glendale, AZ that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for pneumococcal disease treatment options in Glendale, AZ, this clinical trial (NCT06736041) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Glendale research site is actively enrolling participants for this clinical trial. You'll receive care from experienced pneumococcal disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all pneumococcal disease clinical trials near you to find additional studies recruiting in your area.
See all ankylosing spondylitis clinical trials recruiting in Glendale — not just this study.
Browse Ankylosing Spondylitis Trials in Glendale →